Avanos Medical, Inc.
AVNS
$11.44
-$0.14-1.21%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 699.90M | 692.50M | 689.20M | 687.80M | 681.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 699.90M | 692.50M | 689.20M | 687.80M | 681.50M |
| Cost of Revenue | 334.00M | 319.70M | 312.90M | 306.50M | 303.20M |
| Gross Profit | 365.90M | 372.80M | 376.30M | 381.30M | 378.30M |
| SG&A Expenses | 332.40M | 329.50M | 326.90M | 333.80M | 322.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.30M | -600.00K | 1.20M | 3.00M | 2.70M |
| Total Operating Expenses | 677.80M | 658.90M | 651.80M | 655.70M | 641.20M |
| Operating Income | 22.10M | 33.60M | 37.40M | 32.10M | 40.30M |
| Income Before Tax | -487.90M | -477.20M | -395.10M | -403.30M | 26.10M |
| Income Tax Expenses | -19.30M | -15.90M | -14.90M | -17.00M | 4.40M |
| Earnings from Continuing Operations | -468.60 | -461.30 | -380.20 | -386.30 | 21.70 |
| Earnings from Discontinued Operations | -300.00K | -1.90M | -4.40M | -5.80M | -6.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -468.90M | -463.20M | -384.60M | -392.10M | 15.70M |
| EBIT | 22.10M | 33.60M | 37.40M | 32.10M | 40.30M |
| EBITDA | 62.20M | 76.00M | 81.10M | 77.60M | 86.20M |
| EPS Basic | -10.18 | -10.06 | -8.36 | -8.52 | 0.34 |
| Normalized Basic EPS | 0.23 | 0.37 | 0.44 | 0.34 | 0.45 |
| EPS Diluted | -10.19 | -10.07 | -8.38 | -8.54 | 0.33 |
| Normalized Diluted EPS | 0.23 | 0.36 | 0.43 | 0.34 | 0.44 |
| Average Basic Shares Outstanding | 184.80M | 184.40M | 184.00M | 184.10M | 184.30M |
| Average Diluted Shares Outstanding | 185.50M | 185.70M | 185.70M | 185.60M | 186.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |